<HTML>
<HEAD>
<TITLE>Form S-8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 10pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 10pt"><B>FORM S-8</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 10pt"><B>REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</B>
</DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 10pt"><B>VAPOR CORP.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Nevada</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>84-1070932</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or Other
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(I.R.S. Employer</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">Jurisdiction of Incorporation)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Identification Number)</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt">3101 W. Hallandale Blvd<BR>
Suite&nbsp;100<BR>
Hallandale, Florida 33009
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 0pt">(Address, Including Zip Code and Telephone Number, Including Area Code, of<BR>
Registrant&#146;s Principal Executive Offices)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><U>Vapor Corp. Equity Incentive Plan.</U><BR>
(Full title of the plan)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt">Kevin Frija<BR>
President and Chief Executive Officer<BR>
Vapor Corp.<BR>
3101 W. Hallandale Blvd Suite&nbsp;100<BR>
Hallandale, Florida 33009<BR>
(888)&nbsp;482-7671<BR>
(Name, address, including zip code, and telephone number, including area code, of<BR>
agent for service)
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of &#147;large accelerated
filer,&#148; &#147;accelerated filer,&#148; and &#147;smaller reporting company&#148; in Rule&nbsp;12b-2 of the Exchange Act.<BR>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top">Large accelerated filer <FONT face="Wingdings">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Accelerated filer <FONT face="Wingdings">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Non-accelerated filer <FONT face="Wingdings">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><FONT style="white-space: nowrap">Smaller reporting company <FONT face="Wingdings">&#254;</FONT></Font></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>

<TD align="center" valign="top"><FONT style="white-space: nowrap">(Do not check if a smaller reporting company) </FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>CALCULATION OF REGISTRATION FEE</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>

    <TD width="1%">&nbsp;</TD>
</TR><TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="23" style="border-bottom: 3px double #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD>&nbsp;</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Proposed</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Proposed</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD>&nbsp;</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Maximum</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Maximum</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD>&nbsp;</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Amount to</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Offering</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Aggregate</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Amount of</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="left">&nbsp;</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">be</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Price</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Offering</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Registration</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: px solid #000000">Title of Securities to be Registered</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 0px solid #000000">Registered(1)</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 0px solid #000000">Per Share</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 0px solid #000000">Price(2)</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 0px solid #000000">Fee</TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
                    <TD style="border-top: 1px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock,
$0.001 par value</DIV></TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000">5,376,000</TD>
    <TD nowrap style="border-top: 1px solid #000000">(3)</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="right" style="border-top: 1px solid #000000">$</TD>
    <TD align="right" style="border-top: 1px solid #000000">0.44</TD>
    <TD nowrap style="border-top: 1px solid #000000">(5)</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000">$</TD>
    <TD align="right" style="border-top: 1px solid #000000">2,365,440</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000">$</TD>
    <TD align="right" style="border-top: 1px solid #000000">168.66</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock,
$0.001 par value</DIV></TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000">4,624,000</TD>
    <TD nowrap style="border-top: 1px solid #000000">(4)</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap align="right" style="border-top: 1px solid #000000">$</TD>
    <TD align="right" style="border-top: 1px solid #000000">0.48</TD>
    <TD nowrap style="border-top: 1px solid #000000">(2)</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000">$</TD>
    <TD align="right" style="border-top: 1px solid #000000">2,219,520</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000">$</TD>
    <TD align="right" style="border-top: 1px solid #000000">158.25</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000"><DIV style="margin-left:15px; text-indent:-15px"><B>Total</B></DIV></TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000"><B>10,000,000</B></TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000"><B>&#151;</B></TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000"><B>$</B></TD>
    <TD align="right" style="border-top: 1px solid #000000"><B>4,584,960</B></TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000"><B>$</B></TD>
    <TD align="right" style="border-top: 1px solid #000000"><B>326.91</B></TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="23" style="border-top: 3px double #000000">&nbsp;</TD>
</TR>

<!-- End Table Body --></TABLE>
</DIV>




<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR style="font-size: 6pt">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="96">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>Pursuant to Rule&nbsp;416 promulgated under the Securities Act of 1933, as
amended, this registration statement shall be deemed to cover any
additional shares of common stock, par value $0.001 per share, that
become issuable under the Equity incentive Plan by reason of any stock
splits, stock dividends or similar transactions. In addition, this
registration statement also covers an indeterminate amount of
interests to be offered or sold pursuant to the Vapor Corp Equity
Incentive Plan.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>Estimated solely for the purpose of calculating the registration fee
pursuant to Rules 457(c) and (h)&nbsp;promulgated under the Securities Act
of 1933, as amended, by taking the average of the high and low sales
price per share of the common stock on The Pink Sheets Over the
Counter Market on April&nbsp;19, 2010.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(3)</TD>
    <TD>&nbsp;</TD>
    <TD>Represents 5,376,000 common shares issuable upon exercise of options
previously granted under the Vapor Corp. Equity Incentive Plan (the
&#147;Plan&#148;).</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(4)</TD>
    <TD>&nbsp;</TD>
    <TD>Represents 4,624,000 common shares reserved for issuance pursuant to
awards that may be granted under the Plan.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(5)</TD>
    <TD>&nbsp;</TD>
    <TD>Estimated solely for the purpose of calculating the registration fee
pursuant to Rule 457(h) under the Securities Act based upon the
weighted average exercise price of $0.45 per common share for options
for 5,376,000 common shares being registered under this registration
statement.</TD>
</TR>

</TABLE>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">







<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>PART I</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>EXPLANATORY NOTE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">This registration statement contains two parts. The first part contains a &#147;reoffer prospectus&#148;
prepared in accordance with the requirements of Part&nbsp;I of Form S-3 (as permitted by Section&nbsp;C.1. of
the General Instructions to Form S-8). The reoffer prospectus may be used by certain officers and
directors of the Company to sell or otherwise dispose of common shares they receive as grants
under, or as a result of the exercise of options granted or to be granted to them under, the Vapor
Corp. Equity Incentive Plan. The second part contains information required to be included in this
registration statement pursuant to Part&nbsp;II of Form S-8. Pursuant to the introductory note to Part
I of Form S-8, the plan information specified by Part&nbsp;I of Form S-8 is not required to be filed
with the Securities and Exchange Commission (the &#147;SEC&#148;).
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>RESALE PROSPECTUS</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>VAPOR CORP.</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>10,000,000 Common Shares<BR>
(par value $0.001)</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">This prospectus covers the offer and resale of up to 10,000,000 common shares, par value
$0.001 per share, of Vapor Corp., a Nevada company, which may be offered and sold from time to time
by certain, employees, consultants officers and directors of the Company who have acquired or will
acquire such shares pursuant to the Vapor Corp. Equity Incentive Plan (the &#147;Plan&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The common shares may be sold from time to time by the selling shareholders or by their
pledgees, donees, transferees or other successors in interest. Such sales may be made on the Over
the Counter Market or otherwise at prices and at terms then prevailing or at prices related to the
then current market price, or in negotiated transactions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">We will not receive any of the proceeds from the sale of these common shares (except pursuant
to an exercise of options to purchase common shares under the Plan), although we have paid the
expenses of preparing this prospectus and the related registration statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The closing sales price of our common shares on April&nbsp;19, 2010 as reported by the National
Quotation Bureau&#146;s Pink Sheets Market was $0.48.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>You should read this prospectus carefully before you invest. Investing in the common shares
offered hereby involves significant risks. For more information, please see the section of this
prospectus titled &#147;Risk Factors,&#148; in this prospectus.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION
NOR HAS THE COMMISSION PASSED ON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO
THE CONTRARY IS A CRIMINAL OFFENSE.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>THIS PROSPECTUS DOES NOT CONSTITUTE AN OFFER TO SELL SECURITIES IN ANY STATE TO ANY PERSON TO WHOM
IT IS UNLAWFUL TO MAKE SUCH OFFER IN SUCH STATE.</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt">The date of this prospectus is April&nbsp;19, 2010.
</DIV>


<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="left">
<!-- TOC -->
</DIV>
<DIV align="left">
<A name="tocpage"></A>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="77%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#101">Prospectus Summary</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#102">Forward Looking Statements</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#103">Risk Factors</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#104">Use of Proceeds</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#105">Selling Shareholders</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#106">Plan of Distribution</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#107">Legal Matters</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#108">Experts</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#109">Information Incorporated By Reference</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#110">Where You Can Find More Information</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="c00109exv5w1.htm">Exhibit 5.1</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="c00109exv23w2.htm">Exhibit 23.2</A></FONT></TD></TR>
<!-- End Table Body --></TABLE>
</DIV>

<DIV align="left">
<!-- /TOC -->
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">NO PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE ANY REPRESENTATIONS, OTHER THAN
THOSE CONTAINED IN THIS PROSPECTUS, IN CONNECTION WITH THE OFFERING MADE HEREBY, AND, IF GIVEN
OR MADE, SUCH INFORMATION OR REPRESENTATION MUST NOT BE RELIED UPON AS HAVING BEEN AUTHORIZED BY
THE COMPANY OR ANY OTHER PERSON. THE INFORMATION CONTAINED IN THIS PROSPECTUS, AS WELL AS ANY
INFORMATION INCORPORATED BY REFERENCE, IS CURRENT ONLY AS OF THE DATE OF THIS PROSPECTUS OR THE
DATE OF THE DOCUMENT INCORPORATED BY REFERENCE, AS
APPLICABLE. THE COMPANY&#146;S BUSINESS, FINANCIAL CONDITION AND RESULTS OF OPERATIONS MAY HAVE CHANGED
SINCE THAT DATE. THIS PROSPECTUS DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN
OFFER TO BUY ANY SECURITIES OFFERED HEREBY BY ANYONE IN ANY JURISDICTION IN WHICH SUCH OFFER OR
SOLICITATION IS NOT AUTHORIZED OR IN WHICH THE PERSON MAKING SUCH OFFER OR SOLICITATION IS NOT
QUALIFIED TO DO SO OR TO ANY PERSON TO WHOM IT IS UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION.

</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left">
<A name="101"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>PROSPECTUS SUMMARY</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><I>The following is only a summary of some of the information contained or incorporated by reference
in this prospectus that we believe to be important. We have selected highlights of material
aspects of our business to be included in this summary. We urge you to read this entire
prospectus, including the information incorporated by reference in this prospectus. Investing in
our common shares involves risks. You should carefully consider the information below referenced
under the heading &#147;Risk Factors,&#148; in this prospectus and under that heading in our reports filed
with the SEC from time to time.</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">In this prospectus, the words &#147;Company,&#148; &#147;we,&#148; &#147;our&#148; and &#147;us&#148; refer to Vapor Corp. and our
consolidated subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Business</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Vapor Corp. and its wholly-owned subsidiaries (collectively &#147;Vapor&#148; or the &#147;Company&#148;) design,
market, and distribute personal vaporizers, under the Fity-One&#153;, Krave&#153;, EZ Smoker&#153;, Smoke Star&#153;
and Green Puffer&#153; brands. Personal vaporizers are electronic devices that vaporize a liquid
solution, which provide users an experience akin to smoking without actual combustion and as such
no smoke or noxious odor is dispelled from the device. The most common form of personal vaporizers
are &#147;electronic cigarettes&#148; whose solution constituents are primarily propylene glycol, nicotine,
and tobacco flavorings or essences. The company currently sells its personal vaporizers
internationally and domestically through distributors, wholesalers and direct to consumers through
its websites and direct response television marketing efforts.
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Product</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Personal vaporizers are electronic devices, the functional elements of which are integrated into a
stainless steel shell, include: a small plastic cartridge that contains an absorbent material that
is moistened with a propylene glycol liquid solution, which may or may not contain, nicotine,
tobacco flavoring or other flavor essences, an electronic airflow sensor, a heating element,
referred to as the atomizer that vaporizes the liquid in
the mouthpiece so that it can be inhaled, a rechargeable lithium-ion battery which powers the
device and certain electronic components such as a timed cutoff switch to prevent overheating, an
LED to signal activation of the device and an external charger, to recharge the battery.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><IMG src="c00109c0010900.gif" alt="(IMAGE)">
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt">Image presented for illustrative purposes only.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">When a user draws air through the device, the air flow is detected by a sensor, which activates a
heating element that vaporizes the solution stored in the mouthpiece, the solution is then
vaporized and it is this vapor that is inhaled by the user, for pulmonary and or oral
(buccal/mucosal) absorption. The solution depending on the model may or may not contain nicotine,
the flavoring if any, is also based on the particular cartridge and may contain tobacco flavoring
or menthol flavoring, in addition to propylene glycol.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">We sell two and three piece, in addition to disposable personal vaporizers, the distinction between
two and here piece personal vaporizers is the construct of the unit, the number of core parts and
the performance and actual use of the device. We also market, USB, home and car charging devices;
in addition to several varieties of cartridges with varying formulations, including but not limited
to zero nicotine with no flavoring, zero nicotine with tobacco and menthol flavors, in addition to
the standard electronic cigarette filter which contains tobacco flavoring and varying degrees of
nicotine. We sell our products in a kit, or as separate components, we also offer for sale
replacement cartridges to be used with our non-disposable personal vaporizer when the cartridges
become depleted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Our products are relatively new to market, as is the industry in which we operate. Regulations are
emerging that will shape the manner and form in which we operate our business and develop our
business plans and strategies going forward. We expect that our products will be regulated by the
U.S. Food and Drug Administration (FDA)&nbsp;and other foreign governmental agencies for those
respective countries in which we sell our products, and that complying with said regulations will
be a critical element of our business operations and success.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>The Market for Our Products</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">We currently sell our products through multiple sales and distribution channels, both domestic and
internationally. Our products are sold in retail locations, over the Internet and through our
direct response television marketing campaigns. We believe that the market for personal vaporizers
is substantial and will continue to grow both domestically and abroad.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B><I>Distribution and Sales</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The distribution and sales strategy for our products is tailored to the characteristics of each
market, whether it be geographical or demographical.</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">
Our sales and distribution channels are:
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Internet affiliate marketing through independent sales persons.</TD>
</TR>

<TR style="font-size: 8pt">
    <TD>&nbsp;</TD>
</TR> <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Direct Sales and Distribution, where we have set up our own
distribution directly to retailers.</TD>
</TR>

<TR style="font-size: 8pt">
    <TD>&nbsp;</TD>
</TR> <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Single independent distributors who are responsible for distribution
within a single market.</TD>
</TR>

<TR style="font-size: 8pt">
    <TD>&nbsp;</TD>
</TR> <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Exclusive Territory and Exclusive Channel Distribution, where
distributors have an exclusive territory within a country or an
exclusive right to sell within a distribution channel (e.g. gas
station.)</TD>
</TR>

<TR style="font-size: 8pt">
    <TD>&nbsp;</TD>
</TR> <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Distribution through wholesalers, where we supply either national or
regional wholesalers who then service retailers.</TD>
</TR>

<TR style="font-size: 8pt">
    <TD>&nbsp;</TD>
</TR> <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Internet/E-commerce Sales, where we sell directly to end users through
one of our internet websites and or landing pages.</TD>
</TR>

<TR style="font-size: 8pt">
    <TD>&nbsp;</TD>
</TR> <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Direct response television marketing.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Our distribution and sales channels are supported by internal sales and customer service personnel.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">We generate sales and leads through domestic and international trade-shows, telesales, internet
marketing, internet affiliates and direct response television marketing. We depend on a network of
internal and external sales representatives to maintain and grow our business and the revenues we
generate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Competition</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Numerous vendors sell products that compete with ours; the nature of our competitors is varied as
the market is highly fragmented and the barriers to entry into the business are low. Our direct
competitors sell products that are substantially similar to ours and through the same channels
through which we sell our personal vaporizer products. We compete with these direct competitors for
sales through distributors, wholesalers and retailers, including but not limited to national chain
stores, tobacco shops, gas stations, travel stores, shopping mall kiosks, in addition to direct to
public sales through the internet, mail order and telesales.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">As a general matter, we have access to and market and sell the similar personal vaporizers as our
competitors and since we sell our products at substantially similar prices as our competitors.
Accordingly, the key competitive factors for us and other suppliers of personal vaporizers are the
quality of service to customers, the scope and effectiveness of marketing efforts, including media
advertising campaigns and, increasingly, the ability to identify and develop new sources of
customers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Part of our business strategy focuses on the establishment of contractual relationships with
distributors. We are aware that competitors in the industry also are seeking to enter into such
contractual relationships. In many cases, competitors for such contracts may have far greater
management, human, and financial resources than we do for entering into such contracts and for
attracting distributor relationships.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Certain of our competitors may have better control of their supply and distribution, be, better
established, larger and better financed than our Company, however we believe that as a public
company we will have better access to capital, management and resources needed to build our
business and pursue any regulatory approvals that may be needed in connection with future sales of
our products, as the law demands it.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Additionally, we compete with cigarette companies as our products deliver nicotine like traditional
cigarette products; moreover, tobacco companies like R.J. Reynolds have filed a patent application
for a personal vaporizer-like device which they refer to as a &#147;Tobacco-Containing Smoking Article.&#148;
If R. J. Reynolds or other tobacco companies endeavor to compete against us in the electronic
cigarette and personal vaporizer business, or in the alternative should we receive the proper
approvals to allow us to market our products as a smoking cessation aid, we will find ourselves
competing with not only the world&#146;s largest tobacco companies but the world&#146;s largest
pharmaceutical companies as well. Referred to respectively as <I>big tobacco </I>and <I>big pharma; </I>both big
pharma and big tobacco have limitless resources with which to compete against us.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">If we were to gain FDA regulatory approval to market our products as a smoking cessation aid or
nicotine replacement therapy, we would need to demonstrate similar if not greater efficacy of our
product over the existing smoking cessation aids and nicotine replacement therapies and their
respective track records. Moreover, we would need to be competitive on price and our product would
need to be easier to use. Furthermore, in order to be sold as a drug, our products may require
prescriptions to be bought and as such we would be competing against our drug company competitors
in our efforts to persuade doctors that our product is a better alternative to the current drug
company offerings, in order to ensure doctors will write prescriptions for our products.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Both pharmaceutical and tobacco companies have far greater resources than us and we would be hard
pressed to compete successfully against either industry&#146;s participants.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Source and Availability of Raw Materials</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">We believe that an adequate supply of product and raw materials will be available to us as needed
and from multiple sources and suppliers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Trademarks</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">We have filed trademark applications for our brands, Krave&#153;, EZsmoker&#153;, Smoke Star&#153;, Fifty-One&#153; and
Green Puffer&#153;, these trade names which we have established
and used in commerce are at various stages of the trademark application process, none of which have
been awarded to us to date, however we continue to invest in marketing and promoting these brands.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Government Regulation</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Our industry faces intense scrutiny and regulatory uncertainty. The uncertainty is centered in part
on whether electronic cigarettes are a drug, a drug and a medical device or a tobacco product. The
FDA has asserted that electronic cigarettes are a drug and medical device and are required to be
approved under the Federal Food, Drug and Cosmetic Act (FFDCA)&nbsp;as such. Electronic cigarette
marketers contend that the device is a tobacco product and should be regulated as such under the
FDA&#146;s new jurisdiction, under the Family Smoking Prevention and Tobacco Control Act (FSPTCA.)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">In early 2009 the FDA issued import alert 66-41 and as a result US Customs has from time to time
temporarily and in some instances indefinitely detained products sent to us by our Chinese
suppliers. Other electronic cigarette companies have been similarly affected and two of whom had
filed a law suit against the FDA challenging its jurisdiction over electronic cigarettes. On
January&nbsp;14, 2010 a federal district court judge ruled that the United States Food and Drug
Administration does not have the authority to seize electronic cigarettes because these products do
not qualify as devices subject to the agency&#146;s regulation. The FDA has subsequently appealed and
the appellate court has issued a stay of the lower courts ruling.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Our operating plans and marketing strategies are contingent on rulings by the appellate court, the
federal district court and regulations as promulgated by the FDA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">If electronic cigarettes are determined to be regulated as tobacco products, we may be subject to
federal and state labeling, marketing and advertising laws specific to tobacco products, in
addition to any and all applicable federal and state taxes, our products may also be regulated by
the FDA under FSPTCA; which empowers the FDA to establish an approval procedure for the
introduction of new tobacco products to market and regulates the manner and to whom tobacco
products are sold.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">If electronic cigarettes determined to be regulated as drugs, as defined by the FFDCA, we will
likely be required, in order to continue to market our products, to seek regulatory approval in
accordance with the FDA&#146;s prescribed processes for the introduction of a new drug and or medial
device.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Employees</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">We employ 18 full-time employees. Our employees are not unionized and we believe we have good
relations with our employees.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Our principal executive office is located 3101 W. Hallandale Boulevard Suite&nbsp;100, Hallandale
Florida 33009, and our telephone number is (888)&nbsp;482-7671. Our website
address is www.vapor-corp.com. Unless specifically incorporated by reference, information
contained in our website is not a part of this prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>The Offering</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Common shares outstanding before the offering
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">60,000,000 shares(1)</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Common shares issuable upon exercise of options or issuance of restricted shares granted or to be granted which may be offered pursuant to this prospectus
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">10,000,000 shares</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Ticker symbol for our common shares
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#147;VPCO&#148;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Use of Proceeds
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">We will not receive any proceeds from the sale of the common shares. We will receive proceeds to the extent that options granted under the Plan, whether currently outstanding or issued in the future, are exercised. We will
use the exercise proceeds, if any, for working capital and general corporate purposes.</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Risk Factors
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">There are risks associated with an investment in the common shares offered by this prospectus. You should carefully consider the risk factors described under &#147;Risk Factors&#148; in this prospectus before making a decision to invest.</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>




<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR style="font-size: 6pt">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="96">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>As of April&nbsp;29, 2010. Does not include common shares issuable upon exercise of
outstanding options.</TD>
</TR>

</TABLE>

<DIV align="left">
<A name="102"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>FORWARD LOOKING STATEMENTS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Some of the statements set forth in this prospectus are forward-looking statements. These
statements involve known and unknown risks, uncertainties and other factors that may cause our or
our industry&#146;s actual results, levels of activity, performance or achievements to be materially
different from any future results, levels of activity, performance, or achievements expressed or
implied by forward-looking statements. Such factors include, among other things, those referred to
under &#147;Risk Factors&#148; and elsewhere in this prospectus.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">In some cases, you can identify forward-looking statements by terminology such as &#147;may,&#148; &#147;will,&#148;
&#147;should,&#148; &#147;expects,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;predicts,&#148; &#147;potential,&#148;
&#147;proposed,&#148; &#147;intended,&#148; or &#147;continue&#148; or the negative of these terms or other comparable
terminology. You should read statements that contain these words carefully, because they discuss
our expectations about our future operating results or our future financial condition or state
other &#147;forward-looking&#148; information. There may be events in the future that we are not able to
accurately predict or control. Before you invest in our securities, you should be aware that the
occurrence of any of the events described in these risk factors and elsewhere in this prospectus
could substantially harm our business, results of operations and financial condition, and that upon
the occurrence of any of these events, the trading price of our securities could decline and you
could lose all or part of your investment. Although we believe that the expectations reflected in
the forward-looking statements are reasonable, we cannot guarantee future results, growth rates,
levels of activity, performance or achievements. We are under no duty to update any of the
forward-looking statements after the date of this prospectus to conform these statements to actual
results.
</DIV>
<DIV align="left">
<A name="103"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>RISK FACTORS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Our business and, accordingly, an investment in our securities involve significant risks. We urge
you to carefully consider the risks incorporated by reference in this prospectus before making an
investment decision, including those risks set forth under &#147;Risk Factors&#148; in Part&nbsp;I, Item&nbsp;1A of our
Annual Report on Form 10-K for the fiscal year ended
December&nbsp;31, 2009 as well as in our other filings with the SEC, all of which may be amended,
supplemented or superseded from time to time by other reports we file with the SEC in the future.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Additional risks and uncertainties not presently known to us or that we currently deem immaterial
may also impair our business operations. If any of these risks were to occur, our business,
financial condition and results of operations could be seriously harmed. In that event, the trading
price of our shares could decline and you may lose all or part of your investment.
</DIV>
<DIV align="left">
<A name="104"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>USE OF PROCEEDS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The shares which may be sold under this prospectus will be sold for the respective accounts of each
of the selling shareholders. Accordingly, we will not realize any proceeds from the sale of the
shares, except that we will derive proceeds if all of the options to purchase common shares
currently outstanding and options that may be issued in the future are exercised. If exercised,
such proceeds will be available to us for working capital and general corporate purposes. No
assurance can be given, however, as to when or if any or all of the options will be exercised. We
will not receive any proceeds from the issuance and vesting of restricted shares under the
Plan. All expenses of the registration of the shares will be paid for by us. See &#147;Selling
Shareholders&#148; and &#147;Plan of Distribution.&#148;
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="left">
<A name="105"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>SELLING SHAREHOLDERS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The following table sets forth (i)&nbsp;the name and relationship to the Company and its affiliates
(within the past three years) of each selling shareholder listed below; (ii)&nbsp;the number of common
shares each selling shareholder owned of record before the offering; (iii)&nbsp;the number of common
shares being offered for sale by such holder pursuant to this prospectus (which represents the
maximum number of shares that could be sold under this prospectus by such holder assuming the
vesting of all awards and exercise of all options); and (iv)&nbsp;the amount of common shares to be
owned by each selling shareholder and (if one percent or more) the percentage of the class to be
owned by such holder assuming such holder disposes of all of the shares being offered pursuant to
this prospectus. The information under this heading relates to resales of shares covered by this
prospectus by persons who are our &#147;affiliates&#148; as that term is defined under federal securities
laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The tabular information below assumes that all the common shares being offered pursuant to the
registration statement of which this prospectus is a part are sold to third parties. However,
because the selling shareholders may offer all or a portion of the shares covered by this
prospectus at any time and from time to time hereafter, the exact number of shares that each
selling shareholder may retain after completion of the offering cannot be determined at this time.
Information concerning the selling shareholders may change from time to time and, to the extent
required, will be set forth in supplements or amendments to this prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The common shares covered by this prospectus may be sold by the selling shareholders, by those
persons or entities to whom they transfer, donate, devise, pledge or distribute their shares or by
other successors in interest. We are registering the common shares for resale by the selling
shareholders set forth below.
</DIV>
<DIV align="center">
<TABLE style="font-size: 8pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="19%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="43%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Common Shares and</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Shares</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Percentage of Class to be</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Beneficially</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Shares</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Owned After the Offering</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Selling Shareholders and their</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Owned Before</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Offered</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6" style="border-bottom: 1px solid #000000"><B>(3)(4)</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Name</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Relation to Us</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>the Offering(1)</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Hereby(2)</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Percent</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Kevin Frija</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President and Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(5)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">900,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:15px; text-indent:-15px">Adam Frija</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director of Licensing and Business Development</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">4,464,720      </TD>
    <TD nowrap>(6)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">600,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,464,720</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Doron Ziv</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director of Subsidiary and Consultant</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">6,945,120      </TD>
    <TD nowrap>(7)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">600,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6,945,120</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11.57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Isaac Galazan</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director of Subsidiary and Consultant</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">4,169,640      </TD>
    <TD nowrap>(8)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">600,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,169,640</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.95</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Adam Laufer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Counsel to the Company and Consultant</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">1,600,000      </TD>
    <TD nowrap>(9)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">600,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,000,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.67</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Jeffrey Holman</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director of Subsidiary and Consultant</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">5,625,547      </TD>
    <TD nowrap>(10)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">600,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,625,547</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9.38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Jacob Levy</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consultant</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">2,976,480      </TD>
    <TD nowrap>(11)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">600,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,976,480</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.96</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Larry Markx</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(12)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="center">
<TABLE style="font-size: 8pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="19%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="43%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Common Shares and</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Shares</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Percentage of Class to be</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Beneficially</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Shares</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Owned After the Offering</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Selling Shareholders and their</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Owned Before</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Offered</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6" style="border-bottom: 1px solid #000000"><B>(3)(4)</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Name</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Relation to Us</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>the Offering(1)</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Hereby(2)</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Percent</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Daniel Hoff</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(12)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Jesse Milkes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(12)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Nicole Zaldeti</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(12)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Orit Gilad</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(12)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Charly Benassayag</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(12)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Eddie Wong</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(13)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Daniel Macadar</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(13)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Dawn Kershaw</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(13)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Glecie Lacorte</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(14)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Jessica Nieves</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(14)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">America Canas</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(14)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Eric Crawford</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(14)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Stephanie Gutierrez</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(14)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Mia Mcleod</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(14)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Thomas Hulse</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(14)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Meital Noy</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(14)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Miriam Buzaglo</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(14)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Shlomi Biton</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consultant</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD nowrap>(15)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">300,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>




<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR style="font-size: 6pt">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="96">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Represents less than 1% of the outstanding common shares.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>The securities &#147;beneficially owned&#148; by an individual are determined in
accordance with the definition of &#147;beneficial ownership&#148; set forth in
the regulations of the SEC under the Securities Exchange Act of 1934,
as amended (the &#147;Exchange Act&#148;), except that it includes all shares
issuable upon exercise of options. They may include securities owned
by or for, among others, the spouse and/or minor children of an
individual and any other relative who has the same home as such
individual, as well as, other securities as to which the individual
has or shares voting or investment power. Beneficial ownership may be
disclaimed as to certain of the securities.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>The amounts for each selling shareholder assume full vesting and
exercise of all outstanding options to purchase common shares held by
that selling shareholder as of the date of this prospectus.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(3)</TD>
    <TD>&nbsp;</TD>
    <TD>The percentage of beneficial ownership shown in the table is based on 60,000,000 common shares issued and outstanding as of April&nbsp;8, 2010.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(4)</TD>
    <TD>&nbsp;</TD>
    <TD>Assuming the sale of all shares covered by this prospectus and that the number of common shares issued and outstanding upon the
completion of the offering will include only such shares together with all other shares issued and outstanding on the date of this
prospectus.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(5)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes 600,000 common shares issuable upon exercise of options which are currently exercisable or become exercisable within 60&nbsp;days of
the date of this prospectus, 300,000 shares issuable pursuant to options not presently exercisable and not exercisable within 60&nbsp;days of
the date of this prospectus. Mr.&nbsp;Frija is our President and Chief Executive Officer.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(6)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes 400,000 common shares issuable upon exercise of options which
are currently exercisable or become exercisable within 60&nbsp;days of the
date of this prospectus, 200,000 common shares issuable pursuant to
options not presently exercisable and not exercisable within 60&nbsp;days
of the date of this prospectus and 4,464,720 common shares. Mr.&nbsp;Adam
Frija is the company&#146;s Director of Licensing and Business Development.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(7)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes 400,000 common shares issuable upon exercise of options which
are currently exercisable or become exercisable within 60&nbsp;days of the
date of this prospectus, 200,000 common shares issuable pursuant to
options not presently exercisable and not exercisable within 60&nbsp;days
of the date of this prospectus and 6,945,120 common shares. Mr.&nbsp;Ziv
is a consultant to the Company.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">




<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR style="font-size: 6pt">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="96">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">(8)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes 400,000 common shares issuable upon exercise of options which
are currently exercisable or become exercisable within 60&nbsp;days of the
date of this prospectus, 200,000 common shares issuable pursuant to
options not presently exercisable and not exercisable within 60&nbsp;days
of the date of this prospectus and 4,169,640 common shares. Mr.
Galazan is a consultant to the Company.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(9)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes 400,000 common shares issuable upon exercise of options which
are currently exercisable or become exercisable within 60&nbsp;days of the
date of this prospectus, 200,000 common shares issuable pursuant to
options not presently exercisable and not exercisable within 60&nbsp;days
of the date of this prospectus and 1,000,000 common shares. Mr.
Laufer is a consultant and outside counsel to the Company.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(10)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes 400,000 common shares issuable upon exercise of options
which are currently exercisable or become exercisable within 60&nbsp;days
of the date of this prospectus, 200,000 common shares issuable
pursuant to options not presently exercisable and not exercisable
within 60&nbsp;days of the date of this prospectus and 5,625,547 common
shares. Mr.&nbsp;Holman is a consultant to the Company.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(11)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes 400,000 common shares issuable upon exercise of options
which are currently exercisable or become exercisable within 60&nbsp;days
of the date of this prospectus, 200,000 common shares issuable
pursuant to options not presently exercisable and not exercisable
within 60&nbsp;days of the date of this prospectus and 2,976,480 common
shares. Mr.&nbsp;Levy is a consultant to the Company.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(12)</TD>
    <TD>&nbsp;</TD>
    <TD>On a per employee basis, includes 25,000 common shares issuable upon
exercise of options which are currently exercisable or become
exercisable within 60&nbsp;days of the date of this prospectus and 35,000
common shares issuable pursuant to options not presently exercisable
and not exercisable within 60&nbsp;days of the date of this prospectus.
Each of these persons are employees of the Company.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(13)</TD>
    <TD>&nbsp;</TD>
    <TD>On a per employee basis, includes 15,000 common shares issuable upon
exercise of options which are currently exercisable or become
exercisable within 60&nbsp;days of the date of this prospectus and 21,000
common shares issuable pursuant to options not presently exercisable
and not exercisable within 60&nbsp;days of the date of this prospectus.
Each of these persons are employees of the Company.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(14)</TD>
    <TD>&nbsp;</TD>
    <TD>On a per employee basis, includes 5,000 common shares issuable upon
exercise of options which are currently exercisable or become
exercisable within 60&nbsp;days of the date of this prospectus and 7,000
common shares issuable pursuant to options not presently exercisable
and not exercisable within 60&nbsp;days of the date of this prospectus.
Each of these persons are employees of the Company.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(15)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes 125,000 common shares issuable upon exercise of options
which are currently exercisable or become exercisable within 60&nbsp;days
of the date of this prospectus and 175,000 common shares issuable
pursuant to options not presently exercisable and not exercisable
within 60&nbsp;days of the date of this prospectus. Mr.&nbsp;Biton is a
consultant to the Company.</TD>
</TR>

</TABLE>

<DIV align="left">
<A name="106"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>PLAN OF DISTRIBUTION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">In this section of the prospectus, the term &#147;selling shareholder&#148; means and includes: (i)&nbsp;the
persons identified in the table above as the selling shareholders and (ii)&nbsp;any of their donees,
pledgees, distributees, transferees or other successors in interest who may (a)&nbsp;receive any of the
common shares offered hereby after the date of this prospectus and (b)&nbsp;offer or sell those shares
hereunder. The decision to sell any shares is within the discretion of the holders thereof,
subject generally to the Company&#146;s policies affecting the timing and manner of sale of common
shares by certain individuals. There can be no assurance that any shares will be sold by the
selling shareholders.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The common shares offered by this prospectus may be sold from time to time directly by the selling
shareholders. Alternatively, the selling shareholders may from time to time offer such shares
through underwriters, brokers, dealers, agents or other intermediaries. The selling shareholders
as of the date of this prospectus have advised us that there were no underwriting or distribution
arrangements entered into with respect to the common shares offered hereby. The distribution of
the common shares by the selling shareholders may be effected (i)&nbsp;in one or more transactions that
may take place on the over the counter market (including one or more block transactions) through
customary brokerage channels, either through brokers acting as agents for the selling shareholders,
or through market makers, dealers or underwriters acting as principals who may resell these shares
on the Over the Counter Market, (ii)&nbsp;in privately-negotiated sales, (iii)&nbsp;by a combination of such
methods or (iv)&nbsp;by other means. These transactions may be effected at market prices prevailing at
the time of sale, at prices related to such prevailing market prices or at other negotiated
prices. Usual and customary or specifically negotiated brokerage fees or commissions may be paid
by the selling shareholders in connection with sales of our common shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The selling shareholders may enter into hedging transactions with broker-dealers in connection with
distributions of the shares or otherwise. In such transactions, broker-dealers may engage in short
sales of the common shares in the course of hedging the positions they assume with the selling
shareholders. The selling shareholders also may sell shares short and redeliver the shares to
close out such short positions. The selling shareholders may enter into option or other
transactions with broker-dealers that require the delivery to the broker-dealer of common
shares. The broker-dealer may then resell or otherwise transfer such common shares pursuant to
this prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The selling shareholders also may lend or pledge common shares to a broker-dealer. The
broker-dealer may sell the common shares so lent, or upon a default the broker-dealer may sell the
pledged common shares pursuant to this prospectus. Any securities covered by this prospectus that
qualify for sale pursuant to Rule&nbsp;144 may be sold under Rule&nbsp;144 rather than pursuant to this
prospectus. The selling shareholders have advised us that they have not entered into any
agreements, understandings or arrangements with any underwriters or broker-dealers regarding the
sale of their securities. There is no underwriter or coordinating broker acting in connection with
the proposed sale of common shares by the selling shareholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Although the common shares covered by this prospectus are not currently being underwritten, the
selling shareholders or their underwriters, brokers, dealers or other agents or other
intermediaries, if any, that may participate with the selling security holders in any offering or
distribution of common shares may be deemed &#147;underwriters&#148; within the meaning of the Securities Act
of 1933, as amended (the &#147;Securities Act&#148;) and any profits realized or commissions received by them
may be deemed underwriting compensation thereunder. Because the selling shareholders may be deemed
to be &#147;underwriters&#148; within the meaning of Section&nbsp;2(11) of the Securities Act, the selling
shareholders will be subject to the prospectus delivery requirements of the Securities Act, which
may include deemed delivery by brokers or dealers pursuant to Rule&nbsp;153 under the
Securities Act in connection with sales effected between brokers or dealers on or through the Over
the Counter Market.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Under applicable rules and regulations under the Exchange Act, any person engaged in a distribution
of common shares offered hereby may not simultaneously engage in market making activities with
respect to the common shares for a period of up to five days preceding such distribution. The
selling shareholders will be subject to the applicable provisions of the Exchange Act and the rules
and regulations promulgated thereunder, including without limitation Regulation&nbsp;M, which provisions
may limit the timing of purchases and sales by the selling shareholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">In order to comply with certain state securities or blue sky laws and regulations, if applicable,
the common shares offered hereby will be sold in such jurisdictions only through registered or
licensed brokers or dealers. In certain states, the common shares may not be sold unless they are
registered or qualified for sale in such state, or unless an exemption from registration or
qualification is available and is obtained.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">We will bear all costs, expenses and fees in connection with the registration of the common shares
offered hereby. However, the selling shareholders will bear any brokerage or underwriting
commissions and similar selling expenses, if any, attributable to the sale of the common shares
offered pursuant to this prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">We have agreed to indemnify certain of the selling shareholders against certain liabilities,
including liabilities under the Securities Act, or to contribute to payments to which any of those
shareholders may be required to make in respect thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">There can be no assurance that the selling shareholders will sell any or all of the securities
offered by them hereby.
</DIV>
<DIV align="left">
<A name="107"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>LEGAL MATTERS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The validity of the issuance of the common shares offered hereby has been passed upon for us by
Adam J Laufer Esq. Attorney at Law.
</DIV>
<DIV align="left">
<A name="108"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>EXPERTS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Our consolidated financial statements incorporated by reference in this prospectus for the fiscal
years ended December&nbsp;31, 2009 have been audited by Paritz &#038; Co., an independent registered public
accounting firm, as stated in their report with respect thereto, and are included in reliance upon
the report of such firm given upon its authority as experts in accounting and auditing.
</DIV>
<DIV align="left">
<A name="109"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>INFORMATION INCORPORATED BY REFERENCE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The SEC allows us to &#147;incorporate by reference&#148; in this prospectus certain of the information we
file with the SEC. This means we can disclose important information to
you by referring you to another document that has been filed separately with the SEC. The
information incorporated by reference is considered to be part of this prospectus, and will modify
and supersede the information included in this prospectus to the extent that the information
incorporated by reference modifies or supersedes the existing information.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The following documents filed with the SEC (File No.&nbsp;000-19001) are incorporated herein by
reference:
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our Annual Report on Form 10-K for the year ended December&nbsp;31, 2009, filed with the SEC on March&nbsp;31, 2010.</TD>
</TR>

<TR style="font-size: 8pt">
    <TD>&nbsp;</TD>
</TR> <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>All other reports filed by us with the SEC pursuant to Sections 13(a) or 15(d) of the Exchange Act since December&nbsp;31, 2009.</TD>
</TR>

<TR style="font-size: 8pt">
    <TD>&nbsp;</TD>
</TR> <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The description of our common shares contained in the section entitled
&#147;Description of Our Capital Stock&#148; in the prospectus included in our
Current report on Form 8-K, as initially filed with the SEC on
November&nbsp;13, 2009.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">All documents filed by us after the date of this registration statement pursuant to Section&nbsp;13(a),
13(c), 14 or 15(d) of the Exchange Act prior to the filing of a post-effective amendment that
indicates that all of the securities offered hereunder have been sold or that deregisters all
securities remaining unsold shall be deemed to be incorporated by reference herein and to be a part
hereof from the date of the filing of such reports and documents.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Any statement contained in a document incorporated by reference herein shall be deemed to be
modified or superseded for purposes of this prospectus to the extent that a statement contained
herein or in any other subsequently filed document which also is or is deemed to be incorporated by
reference herein modifies or supersedes such statement. Any such statement so modified or
superseded shall not be deemed, except as so modified or superseded, to constitute part of this
prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">We will provide without charge to each person to whom this prospectus is delivered, upon written or
oral request of that person, a copy of all documents incorporated by reference into the
registration statement of which this prospectus is a part, other than exhibits to those documents
(unless such exhibits are specifically incorporated by reference into such documents). Requests for
such documents should be directed to Secretary, Vapor Corp. 3301 W. Hallandale Blvd. Suite&nbsp;100,
Hallandale Florida 33009 telephone: (888)&nbsp;482-7671.
</DIV>
<DIV align="left">
<A name="110"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>WHERE YOU CAN FIND MORE INFORMATION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">We file annual, quarterly and current reports, proxy statements and other information with the
SEC. You may read and copy, upon payment of a fee set by the SEC, any documents that we file with
the SEC as its public reference room at 100 F Street, N.E., Washington, D.C. 20549. You may also
call the SEC at (800)&nbsp;SEC-0330 for more information on the public reference room. Our filings are
also available to the public on
the Internet through the SEC&#146;s EDGAR database. You may access the EDGAR database at the SEC&#146;s
website at www.sec.gov. The information we file with the SEC and other information about us is
also available on our website at www.vapor-corp.com, free of charge. However, the information on
our website is not incorporated into this prospectus and you should not consider information
contained on the SEC&#146;s website or our website to be part of this prospectus.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">This prospectus is part of a registration statement on Form S-8 that we have filed with the SEC to
register the common shares offered hereby under the Securities Act. As permitted by SEC rules, this
prospectus does not contain all of the information contained in the registration statement and
accompanying exhibits and schedules that we file with the SEC. You may refer to the registration
statement, the exhibits and schedules for more information about us and our common shares. The
registration statement, exhibits and schedules are available at the SEC&#146;s public reference room or
through its EDGAR database on the Internet.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">You should rely only on the information contained in this prospectus or any supplement to this
prospectus. We have not authorized anyone to provide you with different information.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>PART II</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;3. Incorporation of Documents by Reference.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The SEC allows us to &#147;incorporate by reference&#148; the information we file with it, which means that
we can disclose important information to you by referring you to those documents. The information
incorporated by reference is considered to be part of this registration statement, and information
that we file later with the SEC will automatically update and supersede this information. We
incorporate by reference the documents filed with SEC listed below:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">1.&nbsp;Our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2009, filed
on March&nbsp;31, 2010;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">2.&nbsp;All other Reports filed by us with the United States Securities and Exchange
pursuant to section 13(a) or 15(d) of the Exchange Act since December
31, 2009; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">3.&nbsp;The description of our Capital Stock contained in our Current Report on Form 8-k
filed with the SEC on November&nbsp;13, 2009.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Furthermore, all reports and other documents subsequently filed by us with the SEC pursuant to
Sections&nbsp;13(a), 13(c), 14, or 15(d) of the Securities Exchange Act of 1934
prior to the filing of a post-effective amendment which indicates that all securities offered have
been sold or which deregisters all securities then remaining unsold shall be deemed to be
incorporated by reference in this registration statement and to be a part of this registration
statement from the date of filing of such reports and documents.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Any statement contained in any document incorporated or deemed to be incorporated by reference
herein shall be deemed to be modified or superseded for purposes of this registration statement to
the extent that a statement contained in this registration statement or in any other subsequently
filed document which also is or is deemed to be incorporated by reference in this registration
statement modifies or supersedes such statement. Any statement so modified or superseded shall not
be deemed, except as so modified or superseded, to constitute a part of this registration
statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;4. Description of Securities.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The class of securities to be offered is registered under Section&nbsp;12 of the Securities Exchange Act
of 1934.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;5. Interests of Named Experts and Counsel.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Our Attorney, Adam J. Laufer Esq., who has given an opinion upon the validity of the securities
being registered, is a holder of shares of our Common Stock and a recipient of shares covered under
this registration statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;6. Indemnification of Directors and Officers.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Our By-Laws provide for the indemnification of directors, officers, employees and agents of the
Company to the fullest extent provided by the Business Corporation Law of the State of Nevada.
These sections generally provide that the Company may indemnify any person who was or is a party to
any threatened, pending or completed action, suit or proceeding whether civil, criminal,
administrative or investigative except for an action by or in right of the corporation by reason of
the fact that he or she is or was a director, officer, employee or agent of the corporation.
Generally, no indemnification may be made where the person has been determined to be negligent or
guilty of misconduct in the performance of his or her duties to the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">At present, there is no pending litigation or proceeding involving a director, officer, employee or
agent of the Corporation where indemnification will be required or permitted. We are not aware of
any threatened litigation or proceeding that may result in a claim for indemnification by any
director or officer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The Company&#146;s By-Laws provide that it will indemnify its Directors and Officers, and hold them
harmless to the fullest extent legally permissible under the Business Corporation Law of the State
of Nevada. These rights of indemnification shall not be exclusive of any other right which any
Officer or Director may have or may thereafter acquire under any by-law, agreement, vote of
stockholders, provision of law or otherwise.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->15<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The By-Laws require the Company to pay all expenses, liability and losses (including attorney fees,
judgments, fines and amounts paid or to be paid in the settlement of a matter), which are
reasonably incurred or suffered by the Officer or Director. Any expenses of the Officer or Director
incurred in defending a civil or criminal action, suit or proceeding must be paid by the Company as
they are incurred in an advance of the final determination of the action, suit or proceeding upon
receipt of an undertaking by or on behalf of the Director or Officer to repay the amount if it is
ultimately determined by a court of competent jurisdiction that he or she is not entitled to be
indemnified by the Corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Insofar as indemnification for liabilities arising under the Securities Act of 1933 (the &#147;Act&#148;) may
be permitted to directors, officers and controlling persons of the small business issuer pursuant
to the foregoing provisions, or otherwise, the small business issuer has been advised that in the
opinion of the Securities and Exchange Commission such indemnification is against public policy as
expressed in the Act and is, therefore, unenforceable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;7. Exemption from Registration Claimed.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Not applicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;8. Exhibits.</B><BR>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="41%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Exhibit No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Description</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Method of Filing</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated Certificate of Incorporation of Vapor Corp.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Incorporated by
reference to
Exhibit&nbsp;3.1 to the
Registrant&#146;s
Definitive
Information
Statement on
Schedule
DEF-14C filed on
December&nbsp;10, 2009.</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Form of Vapor Corp. Equity Incentive Plan.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Incorporated by
reference to
Exhibit&nbsp;4.1 to the
Registrant&#146;s
Definitive
Information
Statement on
Schedule
DEF-14C filed on
December&nbsp;10, 2009.</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Opinion of Adam J Laufer Esq., legal counsel.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed herewith.</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Adam J Laufer Esq., (included in Exhibit&nbsp;5.1)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed herewith.</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Paritz &#038; Company, independent registered public accounting firm.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed herewith.</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">24.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Powers of Attorney (included in signature page to this registration statement).
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed herewith.</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>




<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR style="font-size: 6pt">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="96">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>In accordance with Item&nbsp;8 of Form S-8, and in lieu of the opinion of counsel or determination
contemplated by Item&nbsp;601(b)(5) of Regulation&nbsp;S-K, the Company hereby undertakes that it will submit
the Plan and all amendments thereto to the Internal Revenue Service (&#147;IRS&#148;) in a timely manner, and
that it will make all
changes required by the IRS in order to qualify the Plan.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->16<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">





<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;9. Undertakings</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">(a)&nbsp;The Company hereby undertakes:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">(1)&nbsp;To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">(i)&nbsp;to include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">(ii)&nbsp;to reflect in the prospectus any facts or events arising after the effective
date of the registration statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set forth in
the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of
securities offered (if the total dollar value of securities offered would not exceed that which was
registered) and any deviation from the low or high end of the estimated maximum offering range may
be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the
aggregate, the changes in volume and price represent no more than a 20&nbsp;percent change in the
maximum aggregate offering price set forth in the &#147;Calculation of Registration Fee&#148; table in the
effective registration statement; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">(iii)&nbsp;to include any material information with respect to the plan of distribution
not previously disclosed in the registration statement or any material change to such information
in the registration statement; provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) of this
section do not apply if the registration statement is on Form S-8 (&#167;239.16b of this chapter), and
the information required to be included in a post-effective amendment by those paragraphs is
contained in reports filed with or furnished to the SEC by the Company pursuant to Section&nbsp;13 or
Section 15(d) of the Exchange Act that are incorporated by reference in this registration
statement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><I>provided, however</I>, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information
required to be included in a post-effective amendment by those paragraphs is contained in reports
filed with or furnished to the Commission by the Company pursuant to Section&nbsp;13 or Section 15(d) of
the Exchange Act that are incorporated by reference in this registration statement.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->17<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">(2)&nbsp;That, for the purpose of determining any liability under the Securities Act, each
such post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">(3)&nbsp;To remove from registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination of the offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">(b)&nbsp;The Company hereby undertakes that, for purposes of determining any liability
under the Securities Act, each filing of the Company&#146;s annual report pursuant to Section 13(a) or
Section 15(d) of the Exchange Act that is incorporated by reference in this registration statement
shall be deemed to be a new registration statement relating to the securities offered herein, and
the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">(c)&nbsp;Insofar as indemnification for liabilities arising under the Securities Act may
be permitted to directors, officers and controlling persons of the Company pursuant to the
foregoing provisions, or otherwise, the Company has been advised that in the opinion of the SEC
such indemnification is against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than
the payment by the Company of expenses incurred or paid by a director, officer or controlling
person of the Company in the successful defense of any action, suit or proceeding) is asserted by
such director, officer or controlling person in connection with the securities being registered,
the Company will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
</DIV>
<DIV align="left">
<A name="111"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable
grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused
this registration statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Hallandale, State of Florida on this 29<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day of April, 2010.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">
<B>VAPOR CORP.</B><BR>
(Registrant)<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">

/s/ Kevin Frija
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Kevin Frija&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->18<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>POWER OF ATTORNEY</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 10pt">We, the undersigned officers and directors of Vapor Corp and each of us, do hereby constitute and
appoint each of Kevin Frija, true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, to do any and all acts and things in our name, place and stead, in
any and all capacities, in connection with this registration statement on Form S-8 under the
Securities, or any registration statement for the same offering that is to be effective upon filing
under the Securities Act, including, without limitation, to sign for us or any of us in our names
in the capacities indicated below any and all amendments or supplements to this registration
statement, including any and all post-effective amendments to the registration statement, and to
sign any and all additional registration statements relating to the same offering of securities as
this registration statement that are filed pursuant to Rule 462(b) under the Securities Act, and to
file the same, with all exhibits thereto, and other documents in connection therewith, with the
Securities and Exchange Commission and any applicable securities exchange or securities
self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full
power and authority to do and perform each and every act and thing requisite and necessary to be
done in and about the premises, as fully to all intents and purposes as he might or could do in
person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their
substitutes or substitute, may lawfully do or cause to be done by virtue hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Pursuant to the requirements of the Securities Act, this registration statement has been signed by
the following persons in the capacities indicated on the dates indicated.<BR>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Signature</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Name &#038; Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top" style="border-bottom: 1px solid #000000"><DIV style="margin-left:0px; text-indent:-0px">/s/ Kevin Frija
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Kevin Frija
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="white-space: nowrap">April&nbsp;19, 2010</FONT></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chairman of the Board of Directors,</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chief Executive Officer and Chief Financial Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->19<!-- /Folio -->
</DIV>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "c00109sv8.htm", "description": "FORM S-8", "secsgml_size_bytes": 134212}]
{"company-data": {"conformed-name": "VAPOR CORP.", "cik": "0000844856", "assigned-sic": "0200", "irs-number": "841070932", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-166492", "film-number": "10794873"}, "business-address": {"street1": "3101 W. HALLANDALE BLVD", "street2": "SUITE 100", "city": "HALLANDALE", "state": "FL", "zip": "33009", "phone": "8888766538"}, "mail-address": {"street1": "3101 W. HALLANDALE BLVD", "street2": "SUITE 100", "city": "HALLANDALE", "state": "FL", "zip": "33009"}, "former-company": {"former-conformed-name": "MILLER DIVERSIFIED CORP", "date-changed": "19920703"}}
Form S-8
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
VAPOR CORP.
(Exact name of registrant as specified in its charter)
Nevada
84-1070932
(State or Other
(I.R.S. Employer
Jurisdiction of Incorporation)
Identification Number)
3101 W. Hallandale Blvd
Suite 100
Hallandale, Florida 33009
(Address, Including Zip Code and Telephone Number, Including Area Code, of
Registrant's Principal Executive Offices)
Vapor Corp. Equity Incentive Plan.
(Full title of the plan)
Kevin Frija
President and Chief Executive Officer
Vapor Corp.
3101 W. Hallandale Blvd Suite 100
Hallandale, Florida 33009
(888) 482-7671
(Name, address, including zip code, and telephone number, including area code, of
agent for service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated
filer," "accelerated filer," and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
o
Accelerated filer
o
Non-accelerated filer
o
Smaller reporting company
þ
(Do not check if a smaller reporting company)
CALCULATION OF REGISTRATION FEE
Proposed
Proposed
Maximum
Maximum
Amount to
Offering
Aggregate
Amount of
be
Price
Offering
Registration
Title of Securities to be Registered
Registered(1)
Per Share
Price(2)
Fee
Common Stock,
$0.001 par value
5,376,000
(3)
$
0.44
(5)
$
2,365,440
$
168.66
Common Stock,
$0.001 par value
4,624,000
(4)
$
0.48
(2)
$
2,219,520
$
158.25
Total
10,000,000
—
$
4,584,960
$
326.91
(1)
Pursuant to Rule 416 promulgated under the Securities Act of 1933, as
amended, this registration statement shall be deemed to cover any
additional shares of common stock, par value $0.001 per share, that
become issuable under the Equity incentive Plan by reason of any stock
splits, stock dividends or similar transactions. In addition, this
registration statement also covers an indeterminate amount of
interests to be offered or sold pursuant to the Vapor Corp Equity
Incentive Plan.
(2)
Estimated solely for the purpose of calculating the registration fee
pursuant to Rules 457(c) and (h) promulgated under the Securities Act
of 1933, as amended, by taking the average of the high and low sales
price per share of the common stock on The Pink Sheets Over the
Counter Market on April 19, 2010.
(3)
Represents 5,376,000 common shares issuable upon exercise of options
previously granted under the Vapor Corp. Equity Incentive Plan (the
"Plan").
(4)
Represents 4,624,000 common shares reserved for issuance pursuant to
awards that may be granted under the Plan.
(5)
Estimated solely for the purpose of calculating the registration fee
pursuant to Rule 457(h) under the Securities Act based upon the
weighted average exercise price of $0.45 per common share for options
for 5,376,000 common shares being registered under this registration
statement.
Table of Contents
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
EXPLANATORY NOTE
This registration statement contains two parts. The first part contains a "reoffer prospectus"
prepared in accordance with the requirements of Part I of Form S-3 (as permitted by Section C.1. of
the General Instructions to Form S-8). The reoffer prospectus may be used by certain officers and
directors of the Company to sell or otherwise dispose of common shares they receive as grants
under, or as a result of the exercise of options granted or to be granted to them under, the Vapor
Corp. Equity Incentive Plan. The second part contains information required to be included in this
registration statement pursuant to Part II of Form S-8. Pursuant to the introductory note to Part
I of Form S-8, the plan information specified by Part I of Form S-8 is not required to be filed
with the Securities and Exchange Commission (the "SEC").
RESALE PROSPECTUS
VAPOR CORP.
10,000,000 Common Shares
(par value $0.001)
This prospectus covers the offer and resale of up to 10,000,000 common shares, par value
$0.001 per share, of Vapor Corp., a Nevada company, which may be offered and sold from time to time
by certain, employees, consultants officers and directors of the Company who have acquired or will
acquire such shares pursuant to the Vapor Corp. Equity Incentive Plan (the "Plan").
The common shares may be sold from time to time by the selling shareholders or by their
pledgees, donees, transferees or other successors in interest. Such sales may be made on the Over
the Counter Market or otherwise at prices and at terms then prevailing or at prices related to the
then current market price, or in negotiated transactions.
We will not receive any of the proceeds from the sale of these common shares (except pursuant
to an exercise of options to purchase common shares under the Plan), although we have paid the
expenses of preparing this prospectus and the related registration statement.
The closing sales price of our common shares on April 19, 2010 as reported by the National
Quotation Bureau's Pink Sheets Market was $0.48.
You should read this prospectus carefully before you invest. Investing in the common shares
offered hereby involves significant risks. For more information, please see the section of this
prospectus titled "Risk Factors," in this prospectus.
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION
NOR HAS THE COMMISSION PASSED ON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO
THE CONTRARY IS A CRIMINAL OFFENSE.
THIS PROSPECTUS DOES NOT CONSTITUTE AN OFFER TO SELL SECURITIES IN ANY STATE TO ANY PERSON TO WHOM
IT IS UNLAWFUL TO MAKE SUCH OFFER IN SUCH STATE.
The date of this prospectus is April 19, 2010.
TABLE OF CONTENTS
Prospectus Summary
1
Forward Looking Statements
6
Risk Factors
7
Use of Proceeds
7
Selling Shareholders
8
Plan of Distribution
10
Legal Matters
12
Experts
12
Information Incorporated By Reference
12
Where You Can Find More Information
13
Exhibit 5.1
Exhibit 23.2
NO PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE ANY REPRESENTATIONS, OTHER THAN
THOSE CONTAINED IN THIS PROSPECTUS, IN CONNECTION WITH THE OFFERING MADE HEREBY, AND, IF GIVEN
OR MADE, SUCH INFORMATION OR REPRESENTATION MUST NOT BE RELIED UPON AS HAVING BEEN AUTHORIZED BY
THE COMPANY OR ANY OTHER PERSON. THE INFORMATION CONTAINED IN THIS PROSPECTUS, AS WELL AS ANY
INFORMATION INCORPORATED BY REFERENCE, IS CURRENT ONLY AS OF THE DATE OF THIS PROSPECTUS OR THE
DATE OF THE DOCUMENT INCORPORATED BY REFERENCE, AS
APPLICABLE. THE COMPANY'S BUSINESS, FINANCIAL CONDITION AND RESULTS OF OPERATIONS MAY HAVE CHANGED
SINCE THAT DATE. THIS PROSPECTUS DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN
OFFER TO BUY ANY SECURITIES OFFERED HEREBY BY ANYONE IN ANY JURISDICTION IN WHICH SUCH OFFER OR
SOLICITATION IS NOT AUTHORIZED OR IN WHICH THE PERSON MAKING SUCH OFFER OR SOLICITATION IS NOT
QUALIFIED TO DO SO OR TO ANY PERSON TO WHOM IT IS UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION.
Table of Contents
PROSPECTUS SUMMARY
The following is only a summary of some of the information contained or incorporated by reference
in this prospectus that we believe to be important. We have selected highlights of material
aspects of our business to be included in this summary. We urge you to read this entire
prospectus, including the information incorporated by reference in this prospectus. Investing in
our common shares involves risks. You should carefully consider the information below referenced
under the heading "Risk Factors," in this prospectus and under that heading in our reports filed
with the SEC from time to time.
In this prospectus, the words "Company," "we," "our" and "us" refer to Vapor Corp. and our
consolidated subsidiaries.
Business
Vapor Corp. and its wholly-owned subsidiaries (collectively "Vapor" or the "Company") design,
market, and distribute personal vaporizers, under the Fity-One™, Krave™, EZ Smoker™, Smoke Star™
and Green Puffer™ brands. Personal vaporizers are electronic devices that vaporize a liquid
solution, which provide users an experience akin to smoking without actual combustion and as such
no smoke or noxious odor is dispelled from the device. The most common form of personal vaporizers
are "electronic cigarettes" whose solution constituents are primarily propylene glycol, nicotine,
and tobacco flavorings or essences. The company currently sells its personal vaporizers
internationally and domestically through distributors, wholesalers and direct to consumers through
its websites and direct response television marketing efforts.
1
Table of Contents
Product
Personal vaporizers are electronic devices, the functional elements of which are integrated into a
stainless steel shell, include: a small plastic cartridge that contains an absorbent material that
is moistened with a propylene glycol liquid solution, which may or may not contain, nicotine,
tobacco flavoring or other flavor essences, an electronic airflow sensor, a heating element,
referred to as the atomizer that vaporizes the liquid in
the mouthpiece so that it can be inhaled, a rechargeable lithium-ion battery which powers the
device and certain electronic components such as a timed cutoff switch to prevent overheating, an
LED to signal activation of the device and an external charger, to recharge the battery.
Image presented for illustrative purposes only.
When a user draws air through the device, the air flow is detected by a sensor, which activates a
heating element that vaporizes the solution stored in the mouthpiece, the solution is then
vaporized and it is this vapor that is inhaled by the user, for pulmonary and or oral
(buccal/mucosal) absorption. The solution depending on the model may or may not contain nicotine,
the flavoring if any, is also based on the particular cartridge and may contain tobacco flavoring
or menthol flavoring, in addition to propylene glycol.
We sell two and three piece, in addition to disposable personal vaporizers, the distinction between
two and here piece personal vaporizers is the construct of the unit, the number of core parts and
the performance and actual use of the device. We also market, USB, home and car charging devices;
in addition to several varieties of cartridges with varying formulations, including but not limited
to zero nicotine with no flavoring, zero nicotine with tobacco and menthol flavors, in addition to
the standard electronic cigarette filter which contains tobacco flavoring and varying degrees of
nicotine. We sell our products in a kit, or as separate components, we also offer for sale
replacement cartridges to be used with our non-disposable personal vaporizer when the cartridges
become depleted.
Our products are relatively new to market, as is the industry in which we operate. Regulations are
emerging that will shape the manner and form in which we operate our business and develop our
business plans and strategies going forward. We expect that our products will be regulated by the
U.S. Food and Drug Administration (FDA) and other foreign governmental agencies for those
respective countries in which we sell our products, and that complying with said regulations will
be a critical element of our business operations and success.
The Market for Our Products
We currently sell our products through multiple sales and distribution channels, both domestic and
internationally. Our products are sold in retail locations, over the Internet and through our
direct response television marketing campaigns. We believe that the market for personal vaporizers
is substantial and will continue to grow both domestically and abroad.
2
Table of Contents
Distribution and Sales
The distribution and sales strategy for our products is tailored to the characteristics of each
market, whether it be geographical or demographical.
Our sales and distribution channels are:
•
Internet affiliate marketing through independent sales persons.
•
Direct Sales and Distribution, where we have set up our own
distribution directly to retailers.
•
Single independent distributors who are responsible for distribution
within a single market.
•
Exclusive Territory and Exclusive Channel Distribution, where
distributors have an exclusive territory within a country or an
exclusive right to sell within a distribution channel (e.g. gas
station.)
•
Distribution through wholesalers, where we supply either national or
regional wholesalers who then service retailers.
•
Internet/E-commerce Sales, where we sell directly to end users through
one of our internet websites and or landing pages.
•
Direct response television marketing.
Our distribution and sales channels are supported by internal sales and customer service personnel.
We generate sales and leads through domestic and international trade-shows, telesales, internet
marketing, internet affiliates and direct response television marketing. We depend on a network of
internal and external sales representatives to maintain and grow our business and the revenues we
generate.
Competition
Numerous vendors sell products that compete with ours; the nature of our competitors is varied as
the market is highly fragmented and the barriers to entry into the business are low. Our direct
competitors sell products that are substantially similar to ours and through the same channels
through which we sell our personal vaporizer products. We compete with these direct competitors for
sales through distributors, wholesalers and retailers, including but not limited to national chain
stores, tobacco shops, gas stations, travel stores, shopping mall kiosks, in addition to direct to
public sales through the internet, mail order and telesales.
3
Table of Contents
As a general matter, we have access to and market and sell the similar personal vaporizers as our
competitors and since we sell our products at substantially similar prices as our competitors.
Accordingly, the key competitive factors for us and other suppliers of personal vaporizers are the
quality of service to customers, the scope and effectiveness of marketing efforts, including media
advertising campaigns and, increasingly, the ability to identify and develop new sources of
customers.
Part of our business strategy focuses on the establishment of contractual relationships with
distributors. We are aware that competitors in the industry also are seeking to enter into such
contractual relationships. In many cases, competitors for such contracts may have far greater
management, human, and financial resources than we do for entering into such contracts and for
attracting distributor relationships.
Certain of our competitors may have better control of their supply and distribution, be, better
established, larger and better financed than our Company, however we believe that as a public
company we will have better access to capital, management and resources needed to build our
business and pursue any regulatory approvals that may be needed in connection with future sales of
our products, as the law demands it.
Additionally, we compete with cigarette companies as our products deliver nicotine like traditional
cigarette products; moreover, tobacco companies like R.J. Reynolds have filed a patent application
for a personal vaporizer-like device which they refer to as a "Tobacco-Containing Smoking Article."
If R. J. Reynolds or other tobacco companies endeavor to compete against us in the electronic
cigarette and personal vaporizer business, or in the alternative should we receive the proper
approvals to allow us to market our products as a smoking cessation aid, we will find ourselves
competing with not only the world's largest tobacco companies but the world's largest
pharmaceutical companies as well. Referred to respectively as
big tobacco
and
big pharma;
both big
pharma and big tobacco have limitless resources with which to compete against us.
If we were to gain FDA regulatory approval to market our products as a smoking cessation aid or
nicotine replacement therapy, we would need to demonstrate similar if not greater efficacy of our
product over the existing smoking cessation aids and nicotine replacement therapies and their
respective track records. Moreover, we would need to be competitive on price and our product would
need to be easier to use. Furthermore, in order to be sold as a drug, our products may require
prescriptions to be bought and as such we would be competing against our drug company competitors
in our efforts to persuade doctors that our product is a better alternative to the current drug
company offerings, in order to ensure doctors will write prescriptions for our products.
Both pharmaceutical and tobacco companies have far greater resources than us and we would be hard
pressed to compete successfully against either industry's participants.
4
Table of Contents
Source and Availability of Raw Materials
We believe that an adequate supply of product and raw materials will be available to us as needed
and from multiple sources and suppliers.
Trademarks
We have filed trademark applications for our brands, Krave™, EZsmoker™, Smoke Star™, Fifty-One™ and
Green Puffer™, these trade names which we have established
and used in commerce are at various stages of the trademark application process, none of which have
been awarded to us to date, however we continue to invest in marketing and promoting these brands.
Government Regulation
Our industry faces intense scrutiny and regulatory uncertainty. The uncertainty is centered in part
on whether electronic cigarettes are a drug, a drug and a medical device or a tobacco product. The
FDA has asserted that electronic cigarettes are a drug and medical device and are required to be
approved under the Federal Food, Drug and Cosmetic Act (FFDCA) as such. Electronic cigarette
marketers contend that the device is a tobacco product and should be regulated as such under the
FDA's new jurisdiction, under the Family Smoking Prevention and Tobacco Control Act (FSPTCA.)
In early 2009 the FDA issued import alert 66-41 and as a result US Customs has from time to time
temporarily and in some instances indefinitely detained products sent to us by our Chinese
suppliers. Other electronic cigarette companies have been similarly affected and two of whom had
filed a law suit against the FDA challenging its jurisdiction over electronic cigarettes. On
January 14, 2010 a federal district court judge ruled that the United States Food and Drug
Administration does not have the authority to seize electronic cigarettes because these products do
not qualify as devices subject to the agency's regulation. The FDA has subsequently appealed and
the appellate court has issued a stay of the lower courts ruling.
Our operating plans and marketing strategies are contingent on rulings by the appellate court, the
federal district court and regulations as promulgated by the FDA.
If electronic cigarettes are determined to be regulated as tobacco products, we may be subject to
federal and state labeling, marketing and advertising laws specific to tobacco products, in
addition to any and all applicable federal and state taxes, our products may also be regulated by
the FDA under FSPTCA; which empowers the FDA to establish an approval procedure for the
introduction of new tobacco products to market and regulates the manner and to whom tobacco
products are sold.
If electronic cigarettes determined to be regulated as drugs, as defined by the FFDCA, we will
likely be required, in order to continue to market our products, to seek regulatory approval in
accordance with the FDA's prescribed processes for the introduction of a new drug and or medial
device.
5
Table of Contents
Employees
We employ 18 full-time employees. Our employees are not unionized and we believe we have good
relations with our employees.
Our principal executive office is located 3101 W. Hallandale Boulevard Suite 100, Hallandale
Florida 33009, and our telephone number is (888) 482-7671. Our website
address is www.vapor-corp.com. Unless specifically incorporated by reference, information
contained in our website is not a part of this prospectus.
The Offering
Common shares outstanding before the offering
60,000,000 shares(1)
Common shares issuable upon exercise of options or issuance of restricted shares granted or to be granted which may be offered pursuant to this prospectus
10,000,000 shares
Ticker symbol for our common shares
"VPCO"
Use of Proceeds
We will not receive any proceeds from the sale of the common shares. We will receive proceeds to the extent that options granted under the Plan, whether currently outstanding or issued in the future, are exercised. We will
use the exercise proceeds, if any, for working capital and general corporate purposes.
Risk Factors
There are risks associated with an investment in the common shares offered by this prospectus. You should carefully consider the risk factors described under "Risk Factors" in this prospectus before making a decision to invest.
(1)
As of April 29, 2010. Does not include common shares issuable upon exercise of
outstanding options.
FORWARD LOOKING STATEMENTS
Some of the statements set forth in this prospectus are forward-looking statements. These
statements involve known and unknown risks, uncertainties and other factors that may cause our or
our industry's actual results, levels of activity, performance or achievements to be materially
different from any future results, levels of activity, performance, or achievements expressed or
implied by forward-looking statements. Such factors include, among other things, those referred to
under "Risk Factors" and elsewhere in this prospectus.
6
Table of Contents
In some cases, you can identify forward-looking statements by terminology such as "may," "will,"
"should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential,"
"proposed," "intended," or "continue" or the negative of these terms or other comparable
terminology. You should read statements that contain these words carefully, because they discuss
our expectations about our future operating results or our future financial condition or state
other "forward-looking" information. There may be events in the future that we are not able to
accurately predict or control. Before you invest in our securities, you should be aware that the
occurrence of any of the events described in these risk factors and elsewhere in this prospectus
could substantially harm our business, results of operations and financial condition, and that upon
the occurrence of any of these events, the trading price of our securities could decline and you
could lose all or part of your investment. Although we believe that the expectations reflected in
the forward-looking statements are reasonable, we cannot guarantee future results, growth rates,
levels of activity, performance or achievements. We are under no duty to update any of the
forward-looking statements after the date of this prospectus to conform these statements to actual
results.
RISK FACTORS
Our business and, accordingly, an investment in our securities involve significant risks. We urge
you to carefully consider the risks incorporated by reference in this prospectus before making an
investment decision, including those risks set forth under "Risk Factors" in Part I, Item 1A of our
Annual Report on Form 10-K for the fiscal year ended
December 31, 2009 as well as in our other filings with the SEC, all of which may be amended,
supplemented or superseded from time to time by other reports we file with the SEC in the future.
Additional risks and uncertainties not presently known to us or that we currently deem immaterial
may also impair our business operations. If any of these risks were to occur, our business,
financial condition and results of operations could be seriously harmed. In that event, the trading
price of our shares could decline and you may lose all or part of your investment.
USE OF PROCEEDS
The shares which may be sold under this prospectus will be sold for the respective accounts of each
of the selling shareholders. Accordingly, we will not realize any proceeds from the sale of the
shares, except that we will derive proceeds if all of the options to purchase common shares
currently outstanding and options that may be issued in the future are exercised. If exercised,
such proceeds will be available to us for working capital and general corporate purposes. No
assurance can be given, however, as to when or if any or all of the options will be exercised. We
will not receive any proceeds from the issuance and vesting of restricted shares under the
Plan. All expenses of the registration of the shares will be paid for by us. See "Selling
Shareholders" and "Plan of Distribution."
7
Table of Contents
SELLING SHAREHOLDERS
The following table sets forth (i) the name and relationship to the Company and its affiliates
(within the past three years) of each selling shareholder listed below; (ii) the number of common
shares each selling shareholder owned of record before the offering; (iii) the number of common
shares being offered for sale by such holder pursuant to this prospectus (which represents the
maximum number of shares that could be sold under this prospectus by such holder assuming the
vesting of all awards and exercise of all options); and (iv) the amount of common shares to be
owned by each selling shareholder and (if one percent or more) the percentage of the class to be
owned by such holder assuming such holder disposes of all of the shares being offered pursuant to
this prospectus. The information under this heading relates to resales of shares covered by this
prospectus by persons who are our "affiliates" as that term is defined under federal securities
laws.
The tabular information below assumes that all the common shares being offered pursuant to the
registration statement of which this prospectus is a part are sold to third parties. However,
because the selling shareholders may offer all or a portion of the shares covered by this
prospectus at any time and from time to time hereafter, the exact number of shares that each
selling shareholder may retain after completion of the offering cannot be determined at this time.
Information concerning the selling shareholders may change from time to time and, to the extent
required, will be set forth in supplements or amendments to this prospectus.
The common shares covered by this prospectus may be sold by the selling shareholders, by those
persons or entities to whom they transfer, donate, devise, pledge or distribute their shares or by
other successors in interest. We are registering the common shares for resale by the selling
shareholders set forth below.
Common Shares and
Shares
Percentage of Class to be
Beneficially
Shares
Owned After the Offering
Selling Shareholders and their
Owned Before
Offered
(3)(4)
Name
Relation to Us
the Offering(1)
Hereby(2)
Number
Percent
Kevin Frija
President and Chief Executive Officer
—
(5)
900,000
—
*
Adam Frija
Director of Licensing and Business Development
4,464,720
(6)
600,000
4,464,720
7.4
Doron Ziv
Director of Subsidiary and Consultant
6,945,120
(7)
600,000
6,945,120
11.57
Isaac Galazan
Director of Subsidiary and Consultant
4,169,640
(8)
600,000
4,169,640
6.95
Adam Laufer
Counsel to the Company and Consultant
1,600,000
(9)
600,000
1,000,000
1.67
Jeffrey Holman
Director of Subsidiary and Consultant
5,625,547
(10)
600,000
5,625,547
9.38
Jacob Levy
Consultant
2,976,480
(11)
600,000
2,976,480
4.96
Larry Markx
Employee
—
(12)
60,000
—
*
8
Table of Contents
Common Shares and
Shares
Percentage of Class to be
Beneficially
Shares
Owned After the Offering
Selling Shareholders and their
Owned Before
Offered
(3)(4)
Name
Relation to Us
the Offering(1)
Hereby(2)
Number
Percent
Daniel Hoff
Employee
—
(12)
60,000
—
*
Jesse Milkes
Employee
—
(12)
60,000
—
*
Nicole Zaldeti
Employee
—
(12)
60,000
—
*
Orit Gilad
Employee
—
(12)
60,000
—
*
Charly Benassayag
Employee
—
(12)
60,000
—
*
Eddie Wong
Employee
—
(13)
36,000
—
*
Daniel Macadar
Employee
—
(13)
36,000
—
*
Dawn Kershaw
Employee
—
(13)
36,000
—
*
Glecie Lacorte
Employee
—
(14)
12,000
—
*
Jessica Nieves
Employee
—
(14)
12,000
—
*
America Canas
Employee
—
(14)
12,000
—
*
Eric Crawford
Employee
—
(14)
12,000
—
*
Stephanie Gutierrez
Employee
—
(14)
12,000
—
*
Mia Mcleod
Employee
—
(14)
12,000
—
*
Thomas Hulse
Employee
—
(14)
12,000
—
*
Meital Noy
Employee
—
(14)
12,000
—
*
Miriam Buzaglo
Employee
—
(14)
12,000
—
*
Shlomi Biton
Consultant
—
(15)
300,000
—
*
*
Represents less than 1% of the outstanding common shares.
(1)
The securities "beneficially owned" by an individual are determined in
accordance with the definition of "beneficial ownership" set forth in
the regulations of the SEC under the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), except that it includes all shares
issuable upon exercise of options. They may include securities owned
by or for, among others, the spouse and/or minor children of an
individual and any other relative who has the same home as such
individual, as well as, other securities as to which the individual
has or shares voting or investment power. Beneficial ownership may be
disclaimed as to certain of the securities.
(2)
The amounts for each selling shareholder assume full vesting and
exercise of all outstanding options to purchase common shares held by
that selling shareholder as of the date of this prospectus.
(3)
The percentage of beneficial ownership shown in the table is based on 60,000,000 common shares issued and outstanding as of April 8, 2010.
(4)
Assuming the sale of all shares covered by this prospectus and that the number of common shares issued and outstanding upon the
completion of the offering will include only such shares together with all other shares issued and outstanding on the date of this
prospectus.
(5)
Includes 600,000 common shares issuable upon exercise of options which are currently exercisable or become exercisable within 60 days of
the date of this prospectus, 300,000 shares issuable pursuant to options not presently exercisable and not exercisable within 60 days of
the date of this prospectus. Mr. Frija is our President and Chief Executive Officer.
(6)
Includes 400,000 common shares issuable upon exercise of options which
are currently exercisable or become exercisable within 60 days of the
date of this prospectus, 200,000 common shares issuable pursuant to
options not presently exercisable and not exercisable within 60 days
of the date of this prospectus and 4,464,720 common shares. Mr. Adam
Frija is the company's Director of Licensing and Business Development.
(7)
Includes 400,000 common shares issuable upon exercise of options which
are currently exercisable or become exercisable within 60 days of the
date of this prospectus, 200,000 common shares issuable pursuant to
options not presently exercisable and not exercisable within 60 days
of the date of this prospectus and 6,945,120 common shares. Mr. Ziv
is a consultant to the Company.
9
Table of Contents
(8)
Includes 400,000 common shares issuable upon exercise of options which
are currently exercisable or become exercisable within 60 days of the
date of this prospectus, 200,000 common shares issuable pursuant to
options not presently exercisable and not exercisable within 60 days
of the date of this prospectus and 4,169,640 common shares. Mr.
Galazan is a consultant to the Company.
(9)
Includes 400,000 common shares issuable upon exercise of options which
are currently exercisable or become exercisable within 60 days of the
date of this prospectus, 200,000 common shares issuable pursuant to
options not presently exercisable and not exercisable within 60 days
of the date of this prospectus and 1,000,000 common shares. Mr.
Laufer is a consultant and outside counsel to the Company.
(10)
Includes 400,000 common shares issuable upon exercise of options
which are currently exercisable or become exercisable within 60 days
of the date of this prospectus, 200,000 common shares issuable
pursuant to options not presently exercisable and not exercisable
within 60 days of the date of this prospectus and 5,625,547 common
shares. Mr. Holman is a consultant to the Company.
(11)
Includes 400,000 common shares issuable upon exercise of options
which are currently exercisable or become exercisable within 60 days
of the date of this prospectus, 200,000 common shares issuable
pursuant to options not presently exercisable and not exercisable
within 60 days of the date of this prospectus and 2,976,480 common
shares. Mr. Levy is a consultant to the Company.
(12)
On a per employee basis, includes 25,000 common shares issuable upon
exercise of options which are currently exercisable or become
exercisable within 60 days of the date of this prospectus and 35,000
common shares issuable pursuant to options not presently exercisable
and not exercisable within 60 days of the date of this prospectus.
Each of these persons are employees of the Company.
(13)
On a per employee basis, includes 15,000 common shares issuable upon
exercise of options which are currently exercisable or become
exercisable within 60 days of the date of this prospectus and 21,000
common shares issuable pursuant to options not presently exercisable
and not exercisable within 60 days of the date of this prospectus.
Each of these persons are employees of the Company.
(14)
On a per employee basis, includes 5,000 common shares issuable upon
exercise of options which are currently exercisable or become
exercisable within 60 days of the date of this prospectus and 7,000
common shares issuable pursuant to options not presently exercisable
and not exercisable within 60 days of the date of this prospectus.
Each of these persons are employees of the Company.
(15)
Includes 125,000 common shares issuable upon exercise of options
which are currently exercisable or become exercisable within 60 days
of the date of this prospectus and 175,000 common shares issuable
pursuant to options not presently exercisable and not exercisable
within 60 days of the date of this prospectus. Mr. Biton is a
consultant to the Company.
PLAN OF DISTRIBUTION
In this section of the prospectus, the term "selling shareholder" means and includes: (i) the
persons identified in the table above as the selling shareholders and (ii) any of their donees,
pledgees, distributees, transferees or other successors in interest who may (a) receive any of the
common shares offered hereby after the date of this prospectus and (b) offer or sell those shares
hereunder. The decision to sell any shares is within the discretion of the holders thereof,
subject generally to the Company's policies affecting the timing and manner of sale of common
shares by certain individuals. There can be no assurance that any shares will be sold by the
selling shareholders.
10
Table of Contents
The common shares offered by this prospectus may be sold from time to time directly by the selling
shareholders. Alternatively, the selling shareholders may from time to time offer such shares
through underwriters, brokers, dealers, agents or other intermediaries. The selling shareholders
as of the date of this prospectus have advised us that there were no underwriting or distribution
arrangements entered into with respect to the common shares offered hereby. The distribution of
the common shares by the selling shareholders may be effected (i) in one or more transactions that
may take place on the over the counter market (including one or more block transactions) through
customary brokerage channels, either through brokers acting as agents for the selling shareholders,
or through market makers, dealers or underwriters acting as principals who may resell these shares
on the Over the Counter Market, (ii) in privately-negotiated sales, (iii) by a combination of such
methods or (iv) by other means. These transactions may be effected at market prices prevailing at
the time of sale, at prices related to such prevailing market prices or at other negotiated
prices. Usual and customary or specifically negotiated brokerage fees or commissions may be paid
by the selling shareholders in connection with sales of our common shares.
The selling shareholders may enter into hedging transactions with broker-dealers in connection with
distributions of the shares or otherwise. In such transactions, broker-dealers may engage in short
sales of the common shares in the course of hedging the positions they assume with the selling
shareholders. The selling shareholders also may sell shares short and redeliver the shares to
close out such short positions. The selling shareholders may enter into option or other
transactions with broker-dealers that require the delivery to the broker-dealer of common
shares. The broker-dealer may then resell or otherwise transfer such common shares pursuant to
this prospectus.
The selling shareholders also may lend or pledge common shares to a broker-dealer. The
broker-dealer may sell the common shares so lent, or upon a default the broker-dealer may sell the
pledged common shares pursuant to this prospectus. Any securities covered by this prospectus that
qualify for sale pursuant to Rule 144 may be sold under Rule 144 rather than pursuant to this
prospectus. The selling shareholders have advised us that they have not entered into any
agreements, understandings or arrangements with any underwriters or broker-dealers regarding the
sale of their securities. There is no underwriter or coordinating broker acting in connection with
the proposed sale of common shares by the selling shareholders.
Although the common shares covered by this prospectus are not currently being underwritten, the
selling shareholders or their underwriters, brokers, dealers or other agents or other
intermediaries, if any, that may participate with the selling security holders in any offering or
distribution of common shares may be deemed "underwriters" within the meaning of the Securities Act
of 1933, as amended (the "Securities Act") and any profits realized or commissions received by them
may be deemed underwriting compensation thereunder. Because the selling shareholders may be deemed
to be "underwriters" within the meaning of Section 2(11) of the Securities Act, the selling
shareholders will be subject to the prospectus delivery requirements of the Securities Act, which
may include deemed delivery by brokers or dealers pursuant to Rule 153 under the
Securities Act in connection with sales effected between brokers or dealers on or through the Over
the Counter Market.
11
Table of Contents
Under applicable rules and regulations under the Exchange Act, any person engaged in a distribution
of common shares offered hereby may not simultaneously engage in market making activities with
respect to the common shares for a period of up to five days preceding such distribution. The
selling shareholders will be subject to the applicable provisions of the Exchange Act and the rules
and regulations promulgated thereunder, including without limitation Regulation M, which provisions
may limit the timing of purchases and sales by the selling shareholders.
In order to comply with certain state securities or blue sky laws and regulations, if applicable,
the common shares offered hereby will be sold in such jurisdictions only through registered or
licensed brokers or dealers. In certain states, the common shares may not be sold unless they are
registered or qualified for sale in such state, or unless an exemption from registration or
qualification is available and is obtained.
We will bear all costs, expenses and fees in connection with the registration of the common shares
offered hereby. However, the selling shareholders will bear any brokerage or underwriting
commissions and similar selling expenses, if any, attributable to the sale of the common shares
offered pursuant to this prospectus.
We have agreed to indemnify certain of the selling shareholders against certain liabilities,
including liabilities under the Securities Act, or to contribute to payments to which any of those
shareholders may be required to make in respect thereof.
There can be no assurance that the selling shareholders will sell any or all of the securities
offered by them hereby.
LEGAL MATTERS
The validity of the issuance of the common shares offered hereby has been passed upon for us by
Adam J Laufer Esq. Attorney at Law.
EXPERTS
Our consolidated financial statements incorporated by reference in this prospectus for the fiscal
years ended December 31, 2009 have been audited by Paritz & Co., an independent registered public
accounting firm, as stated in their report with respect thereto, and are included in reliance upon
the report of such firm given upon its authority as experts in accounting and auditing.
INFORMATION INCORPORATED BY REFERENCE
The SEC allows us to "incorporate by reference" in this prospectus certain of the information we
file with the SEC. This means we can disclose important information to
you by referring you to another document that has been filed separately with the SEC. The
information incorporated by reference is considered to be part of this prospectus, and will modify
and supersede the information included in this prospectus to the extent that the information
incorporated by reference modifies or supersedes the existing information.
12
Table of Contents
The following documents filed with the SEC (File No. 000-19001) are incorporated herein by
reference:
•
Our Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 31, 2010.
•
All other reports filed by us with the SEC pursuant to Sections 13(a) or 15(d) of the Exchange Act since December 31, 2009.
•
The description of our common shares contained in the section entitled
"Description of Our Capital Stock" in the prospectus included in our
Current report on Form 8-K, as initially filed with the SEC on
November 13, 2009.
All documents filed by us after the date of this registration statement pursuant to Section 13(a),
13(c), 14 or 15(d) of the Exchange Act prior to the filing of a post-effective amendment that
indicates that all of the securities offered hereunder have been sold or that deregisters all
securities remaining unsold shall be deemed to be incorporated by reference herein and to be a part
hereof from the date of the filing of such reports and documents.
Any statement contained in a document incorporated by reference herein shall be deemed to be
modified or superseded for purposes of this prospectus to the extent that a statement contained
herein or in any other subsequently filed document which also is or is deemed to be incorporated by
reference herein modifies or supersedes such statement. Any such statement so modified or
superseded shall not be deemed, except as so modified or superseded, to constitute part of this
prospectus.
We will provide without charge to each person to whom this prospectus is delivered, upon written or
oral request of that person, a copy of all documents incorporated by reference into the
registration statement of which this prospectus is a part, other than exhibits to those documents
(unless such exhibits are specifically incorporated by reference into such documents). Requests for
such documents should be directed to Secretary, Vapor Corp. 3301 W. Hallandale Blvd. Suite 100,
Hallandale Florida 33009 telephone: (888) 482-7671.
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and current reports, proxy statements and other information with the
SEC. You may read and copy, upon payment of a fee set by the SEC, any documents that we file with
the SEC as its public reference room at 100 F Street, N.E., Washington, D.C. 20549. You may also
call the SEC at (800) SEC-0330 for more information on the public reference room. Our filings are
also available to the public on
the Internet through the SEC's EDGAR database. You may access the EDGAR database at the SEC's
website at www.sec.gov. The information we file with the SEC and other information about us is
also available on our website at www.vapor-corp.com, free of charge. However, the information on
our website is not incorporated into this prospectus and you should not consider information
contained on the SEC's website or our website to be part of this prospectus.
13
Table of Contents
This prospectus is part of a registration statement on Form S-8 that we have filed with the SEC to
register the common shares offered hereby under the Securities Act. As permitted by SEC rules, this
prospectus does not contain all of the information contained in the registration statement and
accompanying exhibits and schedules that we file with the SEC. You may refer to the registration
statement, the exhibits and schedules for more information about us and our common shares. The
registration statement, exhibits and schedules are available at the SEC's public reference room or
through its EDGAR database on the Internet.
You should rely only on the information contained in this prospectus or any supplement to this
prospectus. We have not authorized anyone to provide you with different information.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The SEC allows us to "incorporate by reference" the information we file with it, which means that
we can disclose important information to you by referring you to those documents. The information
incorporated by reference is considered to be part of this registration statement, and information
that we file later with the SEC will automatically update and supersede this information. We
incorporate by reference the documents filed with SEC listed below:
1. Our Annual Report on Form 10-K for the fiscal year ended December 31, 2009, filed
on March 31, 2010;
2. All other Reports filed by us with the United States Securities and Exchange
pursuant to section 13(a) or 15(d) of the Exchange Act since December
31, 2009; and
3. The description of our Capital Stock contained in our Current Report on Form 8-k
filed with the SEC on November 13, 2009.
Furthermore, all reports and other documents subsequently filed by us with the SEC pursuant to
Sections 13(a), 13(c), 14, or 15(d) of the Securities Exchange Act of 1934
prior to the filing of a post-effective amendment which indicates that all securities offered have
been sold or which deregisters all securities then remaining unsold shall be deemed to be
incorporated by reference in this registration statement and to be a part of this registration
statement from the date of filing of such reports and documents.
14
Table of Contents
Any statement contained in any document incorporated or deemed to be incorporated by reference
herein shall be deemed to be modified or superseded for purposes of this registration statement to
the extent that a statement contained in this registration statement or in any other subsequently
filed document which also is or is deemed to be incorporated by reference in this registration
statement modifies or supersedes such statement. Any statement so modified or superseded shall not
be deemed, except as so modified or superseded, to constitute a part of this registration
statement.
Item 4. Description of Securities.
The class of securities to be offered is registered under Section 12 of the Securities Exchange Act
of 1934.
Item 5. Interests of Named Experts and Counsel.
Our Attorney, Adam J. Laufer Esq., who has given an opinion upon the validity of the securities
being registered, is a holder of shares of our Common Stock and a recipient of shares covered under
this registration statement.
Item 6. Indemnification of Directors and Officers.
Our By-Laws provide for the indemnification of directors, officers, employees and agents of the
Company to the fullest extent provided by the Business Corporation Law of the State of Nevada.
These sections generally provide that the Company may indemnify any person who was or is a party to
any threatened, pending or completed action, suit or proceeding whether civil, criminal,
administrative or investigative except for an action by or in right of the corporation by reason of
the fact that he or she is or was a director, officer, employee or agent of the corporation.
Generally, no indemnification may be made where the person has been determined to be negligent or
guilty of misconduct in the performance of his or her duties to the Company.
At present, there is no pending litigation or proceeding involving a director, officer, employee or
agent of the Corporation where indemnification will be required or permitted. We are not aware of
any threatened litigation or proceeding that may result in a claim for indemnification by any
director or officer.
The Company's By-Laws provide that it will indemnify its Directors and Officers, and hold them
harmless to the fullest extent legally permissible under the Business Corporation Law of the State
of Nevada. These rights of indemnification shall not be exclusive of any other right which any
Officer or Director may have or may thereafter acquire under any by-law, agreement, vote of
stockholders, provision of law or otherwise.
15
Table of Contents
The By-Laws require the Company to pay all expenses, liability and losses (including attorney fees,
judgments, fines and amounts paid or to be paid in the settlement of a matter), which are
reasonably incurred or suffered by the Officer or Director. Any expenses of the Officer or Director
incurred in defending a civil or criminal action, suit or proceeding must be paid by the Company as
they are incurred in an advance of the final determination of the action, suit or proceeding upon
receipt of an undertaking by or on behalf of the Director or Officer to repay the amount if it is
ultimately determined by a court of competent jurisdiction that he or she is not entitled to be
indemnified by the Corporation.
Insofar as indemnification for liabilities arising under the Securities Act of 1933 (the "Act") may
be permitted to directors, officers and controlling persons of the small business issuer pursuant
to the foregoing provisions, or otherwise, the small business issuer has been advised that in the
opinion of the Securities and Exchange Commission such indemnification is against public policy as
expressed in the Act and is, therefore, unenforceable.
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
Exhibit No.
Description
Method of Filing
3.1
Amended and Restated Certificate of Incorporation of Vapor Corp.
Incorporated by
reference to
Exhibit 3.1 to the
Registrant's
Definitive
Information
Statement on
Schedule
DEF-14C filed on
December 10, 2009.
4.1
Form of Vapor Corp. Equity Incentive Plan.
Incorporated by
reference to
Exhibit 4.1 to the
Registrant's
Definitive
Information
Statement on
Schedule
DEF-14C filed on
December 10, 2009.
5.1
Opinion of Adam J Laufer Esq., legal counsel.
Filed herewith.
23.1
Consent of Adam J Laufer Esq., (included in Exhibit 5.1)
Filed herewith.
23.2
Consent of Paritz & Company, independent registered public accounting firm.
Filed herewith.
24.1
Powers of Attorney (included in signature page to this registration statement).
Filed herewith.
*
In accordance with Item 8 of Form S-8, and in lieu of the opinion of counsel or determination
contemplated by Item 601(b)(5) of Regulation S-K, the Company hereby undertakes that it will submit
the Plan and all amendments thereto to the Internal Revenue Service ("IRS") in a timely manner, and
that it will make all
changes required by the IRS in order to qualify the Plan.
16
Table of Contents
Item 9. Undertakings
(a) The Company hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
(i) to include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii) to reflect in the prospectus any facts or events arising after the effective
date of the registration statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set forth in
the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of
securities offered (if the total dollar value of securities offered would not exceed that which was
registered) and any deviation from the low or high end of the estimated maximum offering range may
be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the
aggregate, the changes in volume and price represent no more than a 20 percent change in the
maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the
effective registration statement; and
(iii) to include any material information with respect to the plan of distribution
not previously disclosed in the registration statement or any material change to such information
in the registration statement; provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) of this
section do not apply if the registration statement is on Form S-8 (§239.16b of this chapter), and
the information required to be included in a post-effective amendment by those paragraphs is
contained in reports filed with or furnished to the SEC by the Company pursuant to Section 13 or
Section 15(d) of the Exchange Act that are incorporated by reference in this registration
statement;
provided, however
, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information
required to be included in a post-effective amendment by those paragraphs is contained in reports
filed with or furnished to the Commission by the Company pursuant to Section 13 or Section 15(d) of
the Exchange Act that are incorporated by reference in this registration statement.
17
Table of Contents
(2) That, for the purpose of determining any liability under the Securities Act, each
such post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination of the offering.
(b) The Company hereby undertakes that, for purposes of determining any liability
under the Securities Act, each filing of the Company's annual report pursuant to Section 13(a) or
Section 15(d) of the Exchange Act that is incorporated by reference in this registration statement
shall be deemed to be a new registration statement relating to the securities offered herein, and
the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
(c) Insofar as indemnification for liabilities arising under the Securities Act may
be permitted to directors, officers and controlling persons of the Company pursuant to the
foregoing provisions, or otherwise, the Company has been advised that in the opinion of the SEC
such indemnification is against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than
the payment by the Company of expenses incurred or paid by a director, officer or controlling
person of the Company in the successful defense of any action, suit or proceeding) is asserted by
such director, officer or controlling person in connection with the securities being registered,
the Company will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable
grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused
this registration statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Hallandale, State of Florida on this 29
th
day of April, 2010.
VAPOR CORP.
(Registrant)
By:
/s/ Kevin Frija
Kevin Frija
Chief Executive Officer
18
Table of Contents
POWER OF ATTORNEY
We, the undersigned officers and directors of Vapor Corp and each of us, do hereby constitute and
appoint each of Kevin Frija, true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, to do any and all acts and things in our name, place and stead, in
any and all capacities, in connection with this registration statement on Form S-8 under the
Securities, or any registration statement for the same offering that is to be effective upon filing
under the Securities Act, including, without limitation, to sign for us or any of us in our names
in the capacities indicated below any and all amendments or supplements to this registration
statement, including any and all post-effective amendments to the registration statement, and to
sign any and all additional registration statements relating to the same offering of securities as
this registration statement that are filed pursuant to Rule 462(b) under the Securities Act, and to
file the same, with all exhibits thereto, and other documents in connection therewith, with the
Securities and Exchange Commission and any applicable securities exchange or securities
self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full
power and authority to do and perform each and every act and thing requisite and necessary to be
done in and about the premises, as fully to all intents and purposes as he might or could do in
person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their
substitutes or substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, this registration statement has been signed by
the following persons in the capacities indicated on the dates indicated.
Signature
Name & Title
Date
/s/ Kevin Frija
Kevin Frija
April 19, 2010
Chairman of the Board of Directors,
Chief Executive Officer and Chief Financial Officer
19